Boosting early breast and cervical cancer screening in Kenyan communities
Official title: An integrated community-clinic model of optimized implementation strategies to increase early detection of breast and cervical cancers in Kenya
Funded at Implenomics Llcs · NIH-11262940 · Data updated 2026-11-12
This project tests two combined community outreach and clinic-support programs to help women in Kenya get screened for breast and cervical cancer and receive timely follow-up.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Implenomics Llcs NIH-funded |
| Lab location | 1 site (Marblehead, United States) |
| Project start | February 1, 2023 |
| Project end | January 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $566,332 |
| NIH project number | 5R01CA269472-05 |
| Project ID | NIH-11262940 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are women in the participating Kenyan communities who are eligible for breast and cervical cancer screening and have not recently been screened.
✕Less likely to help
People who live outside the study communities, men, or women already undergoing cancer treatment are unlikely to benefit directly from joining.
What this research studies
You may be contacted by trained community health volunteers who offer group education for women and family members about screening options and how to get care. Local clinics will receive practice support to improve how screening is offered, organized, and followed up so teams can work together. Communities will be randomly assigned to different packages so researchers can compare which approach leads to more women getting screened, completing diagnostic tests, and starting treatment when needed. The study will also track costs and implementation outcomes to help plan wider rollout if effective.
Why it matters
Potential benefit: If successful, the approach could increase early detection of breast and cervical cancer and help more women start treatment earlier in Kenya.
How similar studies have gone: Related programs using community health workers and clinic-strengthening have improved screening in other low-resource settings, but combining these multicomponent packages in Kenyan communities at this scale is relatively new.
Where this research is happening
-
Implenomics Llcs
Marblehead, United States Active
Researchers
- Principal investigator: Subramanian, Sujha — Implenomics Llcs
- Study coordinator: Subramanian, Sujha
Related research
Other NIH-funded projects on the same topics.
-
Targeting tumor Lactobacillus iners to help cervical cancer patients
This grant seeks to understand how a specific bacteria, Lactobacillus iners, in cervical tumors affects treatment and outcomes, with the goal of improving therapy for women with cervical cancer.
-
Connecting communities and clinics to increase early breast and cervical cancer screening in Kenya
This project tries two community-plus-clinic programs to help women in Kenya get breast and cervical cancer screening and follow-up care.
-
Understanding bacteria in cervical cancer to improve treatment
This project looks at a specific bacteria found in cervical tumors to find new ways to make treatments work better for women with cervical cancer.
-
Improving early detection of breast and cervical cancers in Kenya
This study is working to help women in Kenya get better access to breast and cervical cancer screenings by connecting community resources and providing education, so they feel more informed and motivated to take care of their health.
-
Improving cervical cancer outcomes by targeting specific bacteria
This study is looking at how a certain bacteria called Lactobacillus iners, found in cervical tumors, might make cervical cancer harder to treat, and it hopes to find new ways to help women with advanced cervical cancer live longer and healthier lives.
-
Moderately hypofractionated radiotherapy after hysterectomy for cervical cancer
This study tests whether a shorter, moderately intensified radiotherapy course after surgery is safe and effective for patients with cervical cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.